Sunday 23 September 2018
Contact US    |    Archive
Channel News Asia
1 months ago

Biogen s pricey muscle drug Spinraza too costly for Britain

Biogen s muscle disease treatment Spinraza has been deemed too expensive for use on Britain s state-run health service, even after a price discount offered by the U.S. drugmaker.

Read on the original site


هذه الصفحة هي مجرد قاریء تلقائي للأخبار باستخدام خدمة الـ RSS و بأن نشر هذه الأخبار هنا لاتعني تأییدها علی الإطلاق.

That ’70s style

- inquirer

The book of Jake

- inquirer

Love, interrupted

- inquirer
Hashtags:   

Biogen

 | 

pricey

 | 

muscle

 | 

drug

 | 

Spinraza

 | 

too

 | 

costly

 | 

for

 | 

Britain

 | 
Most Popular (6 hours)

That ’70s style

- inquirer

Most Popular (24 hours)

Most Popular (a week)